Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cortecs licenses salmon calcitonin to Teva

April 5, 1996

Tsumura Juntendo research into aldose reductase inhibitors

March 15, 1996

AI-401 slated to enter phase II

March 15, 1996

Sankyo reports drugs for diabetes

March 15, 1996

Antidiabetic drugs claimed by Tanabe Seiyaku

March 15, 1996

FDA approves Medtronic's blood processing system

March 15, 1996

New Hemosol division to focus on blood substitutes

March 15, 1996

HemaSure's SteriPath system closer to IDE filing

March 15, 1996

Hematopoietic research at Temple University

March 15, 1996

rHb 1.1 safety demonstrated in surgery patients

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 15, 2025.
ASGCT 2025: Gene and cell therapies transform metabolic diseases
BioWorld Science
Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
Abbott studies show CGM users have fewer hospitalizations
BioWorld MedTech
A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces hospitalizations in people with type 1 diabetes and...
Rznomics in $1.3B Lilly pact to make hearing loss RNA editor drug
BioWorld
Rznomics Inc. scored a potential ₩1.9 trillion (US$1.35 billion) global license option agreement with Eli Lilly and Co. to codevelop a novel RNA editing gene...